Last Updated: June 22, 2026

List of Excipients in API apraclonidine

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing apraclonidine

Subscribe to access the full database, or Start Trial
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Sandoz Inc	APRACLONIDINE	apraclonidine	61314-665	BENZALKONIUM CHLORIDE
Sandoz Inc	APRACLONIDINE	apraclonidine	61314-665	HYDROCHLORIC ACID
Sandoz Inc	APRACLONIDINE	apraclonidine	61314-665	SODIUM ACETATE
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Excipients in ANDA-approved (generic) drugs containing apraclonidine

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC	Excipient
Akorn	apraclonidine hydrochloride	17478-716	BENZALKONIUM CHLORIDE
Akorn	apraclonidine hydrochloride	17478-716	HYDROCHLORIC ACID
Akorn	apraclonidine hydrochloride	17478-716	SODIUM ACETATE
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for apraclonidine

Excipient focus: BENZALKONIUM CHLORIDE

apraclonidine drug variants containing BENZALKONIUM CHLORIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Sandoz Inc	apraclonidine	61314-665
Alcon Laboratories Inc	apraclonidine hydrochloride	0065-0660
Akorn	apraclonidine hydrochloride	17478-716
>Company	>Ingredient	>NDC

apraclonidine drug variants not containing BENZALKONIUM CHLORIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROCHLORIC ACID

apraclonidine drug variants containing HYDROCHLORIC ACID

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Sandoz Inc	apraclonidine	61314-665
Alcon Laboratories Inc	apraclonidine hydrochloride	0065-0660
Akorn	apraclonidine hydrochloride	17478-716
>Company	>Ingredient	>NDC

apraclonidine drug variants not containing HYDROCHLORIC ACID

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM ACETATE

apraclonidine drug variants containing SODIUM ACETATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Sandoz Inc	apraclonidine	61314-665
Alcon Laboratories Inc	apraclonidine hydrochloride	0065-0660
Akorn	apraclonidine hydrochloride	17478-716
>Company	>Ingredient	>NDC

apraclonidine drug variants not containing SODIUM ACETATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM CHLORIDE

apraclonidine drug variants containing SODIUM CHLORIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Sandoz Inc	apraclonidine	61314-665
Alcon Laboratories Inc	apraclonidine hydrochloride	0065-0660
Akorn	apraclonidine hydrochloride	17478-716
>Company	>Ingredient	>NDC

apraclonidine drug variants not containing SODIUM CHLORIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

apraclonidine drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Sandoz Inc	apraclonidine	61314-665
Alcon Laboratories Inc	apraclonidine hydrochloride	0065-0660
Harrow Eye LLC	apraclonidine hydrochloride ophthalmic solution	82667-200
>Company	>Ingredient	>NDC

apraclonidine drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Akorn	apraclonidine hydrochloride	17478-716
>Company	>Ingredient	>NDC

Excipient focus: WATER

apraclonidine drug variants containing WATER

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Sandoz Inc	apraclonidine	61314-665
Alcon Laboratories Inc	apraclonidine hydrochloride	0065-0660
Akorn	apraclonidine hydrochloride	17478-716
>Company	>Ingredient	>NDC

apraclonidine drug variants not containing WATER

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.